MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on July 15, 2008; DOI: 10.1124/mol.108.047993


0026-895X/08/7404-1000-1007$20.00
Mol Pharmacol 74:1000-1007, 2008

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
mol.108.047993v1
74/4/1000    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by García-Cazarín, M. L.
Right arrow Articles by Piascik, M. T.
PubMed
Right arrow PubMed Citation
Right arrow Articles by García-Cazarín, M. L.
Right arrow Articles by Piascik, M. T.

The {alpha}1D-Adrenergic Receptor Induces Vascular Smooth Muscle Apoptosis via a p53-Dependent MechanismFormula

Mary L. García-Cazarín, Jennifer L. Smith, Daret K. St. Clair, and Michael T. Piascik

Departments of Molecular and Biomedical Pharmacology (M.L.G.-C., J.L.S., M.T.P.) and Toxicology (D.K.St.C.), University of Kentucky, Lexington, Kentucky

Activation of the endogenous {alpha}1-adrenergic receptor (AR) associated with human aortic smooth muscle cells resulted in a dose- and time-dependent increase in the levels of mitochondrial reactive oxygen species (ROS). ROS increases were apparent within 10 min and maximal after 45 min. Prolonged activation (>4h) of the {alpha}1-AR resulted in smooth muscle cell apoptosis. Both the increase in ROS and apoptotic cell death were blocked by the nonselective {alpha}1-AR antagonist prazosin as well as the selective {alpha}1D-AR antagonist 8-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-8-azaspiro[4.5]decane-7, 9-dione (BMY 7378). Increases in ROS and apoptosis produced by {alpha}1-AR activation were also blocked by the p38 mitogen-activated protein kinase inhibitor 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)-1H-imidazole (SB 202190) and the NAPDH oxidase inhibitor apocynin. The extracellular signal-regulated kinase 1/2 inhibitor 2'-amino-3'-methoxyflavone (PD 98059) or the c-Jun NH2-terminal kinase inhibitor 1, 9-pyrazoloanthrone anthra(1, 9-cd)pyrazol-6(2H)-one (SP 600125) was without effect on increases in ROS levels or apoptosis. Pifithrin-{alpha}, an inhibitor of the tumor suppressor protein p53, had no effect on ROS generation but did block {alpha}1D-AR-induced apoptosis. Activation of the {alpha}1D-AR resulted in translocation of p53 to the mitochondria. The mitochondrial translocation of p53 was blocked by prazosin, BMY 7378, apocynin, SB 202190, and pifithrin-{alpha}. Apoptosis was also blocked by small interfering RNA directed against p53. These data show that the {alpha}1D-AR is coupled to the generation of mitochondrial ROS by a pathway involving p38 and NADPH oxidase. Sustained activation of the {alpha}1D-AR results in smooth muscle cell apoptosis in a pathway that involves the tumor suppressor protein p53 and the mitochondrial translocation of p53. The data also provide evidence of a linkage between the {alpha}1D-AR and p53.


Received April 23, 2008; accepted July 14, 2008

Address correspondence to: Dr. Michael T. Piascik, Department of Molecular and Biomedical Pharmacology, The University of Kentucky College of Medicine, 800 Rose St., UKMC MS 305, Lexington, KY 40536-0084. E-mail: mtp{at}uky.edu







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2008 by the American Society for Pharmacology and Experimental Therapeutics